Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by BSmartStaycalmon Mar 31, 2018 12:13pm
100 Views
Post# 27810369

RE:RE:Paradigm slashed target from $4.25 to $1.75

RE:RE:Paradigm slashed target from $4.25 to $1.75
rapid_fire_ wrote:
ok, well, the analysts know know the con is up ! and the start of the revisions are just starting ! Cant wait for the hacks on BNN to say " I told you so ! "


LOL hacks on BNN to say ,,, "I told you so !" LIKE you've been saying ????? but I would say "Hack" would be a complement to you rabid_liar_ !!!!!
Bullboard Posts